| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/29/2004 | EP1491889A2 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-beta peptide (x = 41) and tau |
| 12/29/2004 | EP1491888A1 Gel having biosubstance fixed thereto and microarray utilizing the gel |
| 12/29/2004 | EP1491885A1 Method of simultaneous fractional analysis of peracetic acid and hydrogen peroxide |
| 12/29/2004 | EP1491884A1 Biosensor and method of preparation |
| 12/29/2004 | EP1491883A1 Extended use planar sensors |
| 12/29/2004 | EP1491882A2 Biosensing meter and system with pluggable memory key |
| 12/29/2004 | EP1491879A2 Method for the adaptive recognition of a defect on a structured surface |
| 12/29/2004 | EP1491877A1 Active remote sensing using a simultaneous spectral sampling technique |
| 12/29/2004 | EP1491876A1 FTIR ellipsometry device and process for characterization and further identification of samples of complex biogical materials, notably micro-organisms |
| 12/29/2004 | EP1491638A2 Apparatus and method for nucleic acid spatial ordering |
| 12/29/2004 | EP1491636A1 Method of detecting mild impaired glucose tolerance or insulin hyposecretion |
| 12/29/2004 | EP1491631A1 Method of screening transporter inhibitor |
| 12/29/2004 | EP1491629A1 Novel method of highly sensitive nucleic acid analysis |
| 12/29/2004 | EP1491627A1 Gene examination method for judging the onset risk of glaucoma |
| 12/29/2004 | EP1491626A1 Method of assaying target nucleic acid and kit therefor |
| 12/29/2004 | EP1491591A1 New fluorescence cyanine labels containing a sulfamido linker arm |
| 12/29/2004 | EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491505A1 Method of measuring and controlling the formation of biofilms in a watersystem |
| 12/29/2004 | EP1491259A1 Centrifuging member and device for using this member |
| 12/29/2004 | EP1491209A1 Diagnostics and remedies for interstitial pneumonia |
| 12/29/2004 | EP1491144A1 Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
| 12/29/2004 | EP1491134A1 Blood sugar level measuring apparatus |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490887A2 Microscale sensor element and related device and method of manufacture |
| 12/29/2004 | EP1490826A2 Methods of evaluating dna-based links |
| 12/29/2004 | EP1490823A1 A method for gene mapping from genotype and phenotype data |
| 12/29/2004 | EP1490789A2 Early detection of sepsis |
| 12/29/2004 | EP1490768A1 Adaptive behavioral intrusion detection systems and methods |
| 12/29/2004 | EP1490698A1 Automatic crucible and sample loading system and method |
| 12/29/2004 | EP1490697A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
| 12/29/2004 | EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 12/29/2004 | EP1490695A1 Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain |
| 12/29/2004 | EP1490694A1 Camp-regulated phosphorprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 12/29/2004 | EP1490693A1 Method for characterising analytes |
| 12/29/2004 | EP1490692A2 Diagnostic and therapeutic use of caps |
| 12/29/2004 | EP1490691A2 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
| 12/29/2004 | EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 12/29/2004 | EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr |
| 12/29/2004 | EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11 |
| 12/29/2004 | EP1490687A1 Methods for detecting ovarian cancer |
| 12/29/2004 | EP1490684A1 Method and device for trichomonas detection |
| 12/29/2004 | EP1490682A1 Detection of dna-binding proteins |
| 12/29/2004 | EP1490681A2 Peptide screen |
| 12/29/2004 | EP1490680A2 Identifying peptide modifications |
| 12/29/2004 | EP1490678A2 Compositions and methods for modeling bacillus subtilis metabolism |
| 12/29/2004 | EP1490677A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 12/29/2004 | EP1490673A2 Device and method for carrying out and continuously monitoring chemical and/or biological reactions |
| 12/29/2004 | EP1490672A2 An electrical condition monitoring method for polymers |
| 12/29/2004 | EP1490668A1 Method and apparatus for storing and dispensing reagents |
| 12/29/2004 | EP1490666A1 Sidestream gas sampling system with detachable sample cell |
| 12/29/2004 | EP1490665A2 Rapid and non-invasive method to evaluate immunization status of a patient |
| 12/29/2004 | EP1490519A2 Life sciences business systems and methods |
| 12/29/2004 | EP1490516A1 Interpreting cytological specimens via molecular histological signatures |
| 12/29/2004 | EP1490514A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 12/29/2004 | EP1490511A2 Methods and systems for dynamic gene expression profiling |
| 12/29/2004 | EP1490509A2 Modulating insulin receptor signaling |
| 12/29/2004 | EP1490504A1 Method and apparatus for monitoring a fermentation process |
| 12/29/2004 | EP1490502A2 Screening method for predicting susceptibility to breast cancer |
| 12/29/2004 | EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21 |
| 12/29/2004 | EP1490493A1 Enhancer sequence of the 5-aminolevulinic acid synthase gene |
| 12/29/2004 | EP1490486A2 Method of identifying genes controlling diferentiation |
| 12/29/2004 | EP1490474A2 Method for producing pseudo islets |
| 12/29/2004 | EP1490399A2 Human diabetes-mediating proteins |
| 12/29/2004 | EP1490394A1 Method and apparatus for the identification and qualification of biomolecules |
| 12/29/2004 | EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9 |
| 12/29/2004 | EP1490387A2 A human ribonucleotide reductase m2 subunit |
| 12/29/2004 | EP1490386A2 Novel polypeptides and nucleic acids encoding the same |
| 12/29/2004 | EP1490384A2 A building block forming a c-c bond upon reaction |
| 12/29/2004 | EP1490381A1 Human gene critical to fertility |
| 12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 12/29/2004 | EP1490359A1 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| 12/29/2004 | EP1490348A1 Labelled taxanes |
| 12/29/2004 | EP1490213A1 Multiple-property composite beads and preparation and use thereof |
| 12/29/2004 | EP1490175A2 Microarray device |
| 12/29/2004 | EP1490111A2 Edg-receptor agonists for the treatment of hypertension |
| 12/29/2004 | EP1490110A2 Anti-alpha v beta 6 antibodies |
| 12/29/2004 | EP1490085A2 Fc receptor homolog, reagents, and uses thereof |
| 12/29/2004 | EP1490084A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car |
| 12/29/2004 | EP1490076A2 Novel metabolic targets and markers |
| 12/29/2004 | EP1490067A2 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 12/29/2004 | EP1490023A2 Drug signatures |
| 12/29/2004 | EP1489968A2 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples |
| 12/29/2004 | EP1489962A1 System and method for managing a patient treatment program |
| 12/29/2004 | EP1489961A2 Improving performance of an analyte monitoring device |
| 12/29/2004 | EP1456399A4 Total cysteine assay |
| 12/29/2004 | EP1446497A4 Methods of screening for toxicity of test compounds |
| 12/29/2004 | EP1427532A4 Multi-layer coated porous materials and methods of making the same |
| 12/29/2004 | EP1425577A4 Apparatuses and methods for creating and testing pre-formulations and systems for same |
| 12/29/2004 | EP1412727A4 Method for interpreting tandem mass spectrometry data for clinical diagnosis |
| 12/29/2004 | EP1389947A4 Methods to diagnose treat and prevent bone loss |
| 12/29/2004 | EP1379537A4 Pcr-hybridization assays specific for integrated retroviruses |
| 12/29/2004 | EP1274466A4 Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
| 12/29/2004 | EP1261920A4 On-site agricultural product analysis system and method of analyzing |
| 12/29/2004 | EP1255852A4 Immunoassay and diagnostic reagent for malaria |
| 12/29/2004 | EP1252521B1 Process for the identification of igg-producing cells |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | EP1222312B1 Multiplex pcr for detecting ehec infections |
| 12/29/2004 | EP1214345B1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 12/29/2004 | EP1179181A4 Microscale diffusion immunoassay |